Ligand Pharmaceuticals
LGND
#3727
Rank
C$5.02 B
Marketcap
C$255.17
Share price
-1.91%
Change (1 day)
46.87%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.72 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are C$0.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.15 B39.57%
2023-12-31C$0.11 B-48.93%
2022-12-31C$0.22 B-63.08%
2021-12-31C$0.60 B-27.05%
2020-12-31C$0.83 B-12.42%
2019-12-31C$0.95 B-0.31%
2018-12-31C$0.95 B200.47%
2017-12-31C$0.31 B2.33%
2016-12-31C$0.31 B-1.16%
2015-12-31C$0.31 B15.71%
2014-12-31C$0.27 B362.22%
2013-12-31C$58.65 M-24.16%
2012-12-31C$77.33 M-32.35%
2011-12-31C$0.11 B42.25%
2010-12-31C$80.37 M-44.67%
2009-12-31C$0.14 B-34.29%
2008-12-31C$0.22 B53.71%
2007-12-31C$0.14 B-58.65%
2006-12-31C$0.34 B-29.72%
2005-12-31C$0.49 B1.03%
2004-12-31C$0.48 B7.39%
2003-12-31C$0.45 B43.38%
2002-12-31C$0.31 B13.88%
2001-12-31C$0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$161.14 B 22,244.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$158.36 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$117.69 B 16,219.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$110.27 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$19.10 B 2,549.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$106.32 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$97.96 B 13,483.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$83.93 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
C$0.11 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA